In normal cells Myc activation increases proliferative rates and provokes transformation by regulating genes that drive metabolism and the cell cycle and by regulating the angiogenic switch (reviewed in reference 33). However, Myc also triggers the apoptotic response (1, 14) , which includes activation of the Arf-p53 tumor suppressor pathway (40) , as well as suppression of the bcl-X and bcl-2 antiapoptotic genes (13) .
Precisely how Myc induces such a wide array of biological responses is unclear, but all of the effects of Myc require its function as a basic helix-loop-helix-leucine zipper (b-HLHZip) transcription factor. The ability of Myc to bind to its recognition element, a CACGTG E-box (8) , and to induce transcription requires dimerization with Max, a small b-HLH-Zip protein (9) . The activity of the Myc-Max complex is thought to be harnessed by other b-HLH-Zip factors, the Mad proteins (2) and Mnt (or "Rox" [20, 29] ), which also dimerize with Max and bind to these elements yet repress transcription through their associations with the general corepressors Sin3a and Sin3b and associated histone deacetylases (3) . These findings, and the expression of some Mad proteins during differentiation (2) , have suggested a model whereby activating Myc-Max complexes are antagonized by repressive Mad-Max or MntMax complexes and the equilibrium between these complexes regulates cell fate. However, other alternatives are equally plausible; for example, Myc could function as an antagonist of Mad and/or Mnt and activate gene expression through the relief of active repression (4) .
If Mad family members functioned to antagonize Myc, then one prediction was that their targeted deletion should release Myc activity to provoke inappropriate cell proliferation, apoptosis and, ultimately, transformation. Surprisingly, the knockouts of Mad1, Mxi1 (Mad2), and Mad3 revealed only modest and selective effects on cell differentiation rather than on cell growth or transformation (15, 35, 36) . By contrast, little is known about the physiological role of Mnt, which, in contrast to Mad factors, is expressed in proliferating cells (20) .
To evaluate the interplay of Myc, Mad, and Mnt in regulating transcription and cell fate, we reevaluated the mechanism by which c-Myc induces the transcription of the Ornithine decarboxylase (Odc) gene, which encodes the rate-limiting enzyme in polyamine biosynthesis. These studies pinpointed Mnt as a key regulator of Odc expression and demonstrated that Myc induces Odc transcription by relief of Mnt-mediated repression. Strikingly, knockdown of Mnt by stable RNA interference established that Mnt loss provokes the typical "Myc" response, even in cells lacking c-myc, and that Mnt behaves as a tumor suppressor.
TTGAGTGTTGTTCCGGTGTTTCGTCCTTTCCACAA. The PCR product was cloned into the NotI site of MSCV-IRES-GFP. 4-Hydroxytamoxifen (4-HT [Sigma]) was used at 1 M. Antibodies against c-Myc (Santa Cruz Biotechnologies), Max (Transduction Labs), Mnt (from Peter Hurlin and Robert Eisenman), Mad1 (Santa Cruz), and USF-1 (Upstate) were used for supershift analyses in electrophoretic mobility shift assays (EMSAs). Antibodies against Mnt (Santa Cruz), E2f1 (Transduction Labs), p27
Kip1 (Transduction Labs), ODC (from Anthony Pegg), p53 (Calbiochem), p19
Arf (Upstate), caspase-9 (Cell Signaling), and Bcl-X 1 . (Transduction Labs) were used for immunoblotting.
Viability and apoptosis assays. To assess the effects of Mnt knockdown on cell survival, green fluorescent protein (GFP)-only-and MntRNAi-expressing cells were seeded in 100-mm plates with 5 ϫ 10 5 cells. After 24 h, the cells were shifted to medium containing 0.1% fetal calf serum and harvested at specific intervals, and their viability was determined by trypan blue dye exclusion. Apoptosis was determined by propidium iodide staining and annexin V-Fluorescein isothiocyanate staining, which was performed as described by the manufacturer (BioWhittaker Inc. Walkersville, Md.). Briefly, 2 ϫ 10 5 to 5 ϫ 10 5 cells were washed in phosphate-buffered saline and resuspended in 190 l of binding buffer (10 mM HEPES [pH 7.4], 140 mM NaCl, 2.5 mM CaCl). A 10-l portion of annexin V-fluorescein isothiocyanate was added, the mixture was incubated for 10 min, and the cells were washed once and resuspended in 190 l of binding buffer. To this was added 10 l of 20-g/ml propidium iodide stock solution. The cells were then analyzed for the presence of apoptotic cells by fluorescence-activated cell sorter analysis.
RNA analysis. RNA was extracted using Trizol (Invitrogen). Northern blot analysis was performed as described previously (31) . Real-time PCR was performed using the Taq-Man EZ reverse transcription-PCR core kit as described by the manufacturer (Applera, Inc.). Primer and probe sequences are available on request.
Odc promoter analyses. EMSAs were performed using extracts as described (24) . Chromatin immunoprecipitations (ChIP) were performed on serumstarved and -stimulated BALB/c-3T3 fibroblasts by using a kit from Upstate and the antibodies described above. The primers used encompassed both E-boxes of the Odc gene. Primer sequences are available on request. Transient transfections of BALB/c-3T3 cells were performed using Lipofectamine 2000 (Invitrogen). The Odc promoter-reporter constructs (ODC⌬Luc and ODC⌬Luc5A) driving the expression of firefly luciferase have been described previously (32) .
RESULTS

Mnt repression of
Odc is relieved by c-Myc. To initially assess which complexes of the Max network might contribute to Odc regulation, we performed EMSAs using antibodies that can supershift in vitro-generated Mad-Max, Myc-Max, and Mnt-Max complexes bound to probes containing the Odc Eboxes (data not shown). As observed in other systems (24) , we failed to detect a Myc-Max complex or any Mad-Max complexes which bound to these elements in cell extracts from proliferating FDC-P1 myeloid cells (Fig. 1A) , from proliferat- (Fig. 1B) , or from wild-type or c-myc Ϫ/Ϫ ES cells (Fig. 1C) . By contrast, a MntMax complex was readily detected in extracts derived from all cell types (Fig. 1A to C) . Moreover, the binding of the MntMax complex was greatly augmented in extracts of c-myc
ES cells over wild-type ES cells (Fig. 1C) , despite an equivalent expression of Mnt (data not shown). Therefore, loss of c-Myc increases the DNA binding activity of the Mnt-Max complex, and real-time PCR analyses established that this was associated with reductions in the level of Odc mRNA in c-myc
compared with wild-type ES cells (Fig. 1D) .
The binding of c-Myc to its response elements has been detected in some targets, such as Cyclin D2, using ChIP assays (10, 16) . We therefore evaluated the occupation of the Odc E-boxes in quiescent and serum-stimulated BALB/c-3T3 fibroblasts (which express Odc at low or high levels [ Fig. 2A , lanes 4 and 5, respectively). As expected, Max bound to these elements irrespective of the growth state of the cells (Fig. 2B) . Interestingly, ChIP assays demonstrated that Mnt occupied the Odc E-boxes in quiescent cells ( Fig. 2B ) but that its binding was abolished in serum-stimulated fibroblasts, despite equivalent levels of the Mnt-Max complex (as determined by EMSA) in proliferating and quiescent cells (Fig. 1B) . Rather, in proliferating fibroblasts ChIP analyses established that Mnt was effectively replaced by c-Myc (Fig. 2B) . Therefore, the induction of Odc by growth factors is associated with the ability of Myc to displace Mnt-Max complexes.
The induction of the Odc promoter by c-Myc (7) and the binding of the Mnt-Max complex present in cells (data not shown) are abolished by CACGTG-to-CACCTG point mutations of these E-boxes. To address whether Mnt would repress the Odc transcription and whether this suppression could be relieved by Myc activation, BALB/c-3T3 fibroblasts engineered to express the tamoxifen-inducible Myc-ER construct (25) were transiently transfected with Odc promoter-reporters and a Mnt expression construct. As expected, Mnt repressed Odc promoter activity, and this was dependent on the E-boxes. Moreover, activation of Myc-ER with 4-HT effectively relieved Mnt-mediated repression of the Odc promoter (Fig. 2C ). Therefore, Myc antagonizes Mnt-mediated repression of Odc transcription.
Knockdown of Mnt expression accelerates growth, triggers apoptosis, and provokes transformation. Collectively, these data were consistent with a model whereby Myc activates Odc through the displacement of Mnt, which binds to Odc E-boxes to repress transcription. If this scenario was generally true, then the effects of Mnt loss should essentially mimic those of Myc overexpression. To address this issue, we generated a retroviral vector (MSCV-MntRNAi-IRES-GFP) that expresses a short hairpin RNA (shRNA) that targets both mouse and rat Mnt mRNA, driven by the U6 RNA polymerase III promoter (19) . Two fibroblast cell lines, mouse BALB/c-3T3 (30) and rat HO.15 c-myc Ϫ/Ϫ cells (27) , and early-passage (passage 3) mouse embryonic fibroblasts (MEFs) were transduced with MSCV-MntRNAi-IRES-GFP virus, which also expresses the gene for GFP by virtue of an internal ribosome entry site (IRES). As a control, these cells were also infected in parallel with a MSCV-IRES-GFP virus and infected cells were sorted by flow cytometry for GFP. Using this strategy, there was a specific ablation of Mnt protein levels in all three MntRNAiexpressing fibroblast strains (see Fig. 7A ).
The hallmarks of Myc-overexpressing fibroblasts include accelerated rates of cell proliferation and changes in morphology to more refractile cells (27, 40) . Strikingly, all cells expressing MntRNAi showed immediate and obvious effects of Mnt knockdown, since these fibroblasts were more refractile and proliferated at an accelerated rate (Fig. 3) . Most notably, these changes were particularly evident in c-myc Ϫ/Ϫ fibroblasts, which also fail to express N-Myc or L-Myc (27) ; therefore, Mnt knockdown is sufficient to provoke the accelerated growth of fibroblasts independently of Myc. Myc overexpression in fibroblasts also triggers apoptosis when cells are deprived of the survival factors present in serum (14, 18) . As judged by their ability to exclude the vital dye trypan blue (Fig. 4A) , by the appearance of annexin V-positive cells by FACS (Fig. 4B) , and by the cleavage of pro-caspase-9 (Fig. 7C) , all MntRNAi-expressing fibroblasts underwent rapid apoptosis when deprived of serum whereas GFP-only-expressing cells survived the withdrawal of serum. Again, since effects were obvious in c-myc Ϫ/Ϫ fibroblasts, apoptosis triggered by Mnt knockdown can also be Myc independent.
To rule out the possibility that the effects on cell proliferation and apoptosis were not in fact due to the expression of a short hairpin RNA, we designed three additional shRNAiencoding retroviruses, one encoding an shRNAi targeting a sequence from pBluescript (which, according to BLAST searches, is not present in the mouse genome) and two additional shRNAi targeting Mnt. Together with the original MSCV-MntRNAi-IRES-GFP virus, these retroviruses were introduced into MEFs and assayed for cell proliferation and apoptosis. As is evident in Fig. 5A , all three MntRNAi constructs were very efficient in knocking down Mnt expression whereas cells expressing pBlueRNAi still expressed Mnt. Again, the effects of Mnt knockdown were remarkable, with changes in morphology (data not shown), increased cell pro- (Fig. 5B) , and induction of cell death following serum starvation (Fig. 5C ).
Myc also provokes transformation of primary fibroblasts in conjunction with activated Ha-Ras (22), and we therefore also assessed effects of Mnt knockdown on tumorigenesis. MEFs were transduced with MSCV-MntRNAi-IRES-GFP virus and pBabe-Ha-Ras V12 -puro virus (which expresses activated HaRas and the puromycin resistance gene) or with control GFPand puromycin-only-expressing viruses. Infected cells were selected for GFP and for growth in puromycin medium for 2 days and immediately plated in soft agar or injected into immunocompromised Nu/Nu mice (n ϭ 5). In soft-agar assays, MEFs expressing MntRNAi alone were capable of forming colonies, although these were much smaller and were reduced 10-to 20-fold relative to the numbers of colonies observed in MEFs expressing both MntRNAi and Ha-Ras ( vival, and transformation. Importantly, since these effects occur even in c-myc Ϫ/Ϫ Rat1a fibroblasts that lack all forms of Myc (27) , the phenotypes provoked by Mnt knockdown can be Myc independent.
Mnt loss triggers "Myc" transcriptional programs. The surprising similarities in the biological responses to knockdown of Mnt versus Myc overexpression, even in fibroblasts lacking c-myc, suggested that gene programs regulated by Myc might be due to relief of Mnt-mediated repression. We therefore assessed pathways triggered by Myc in fibroblasts expressing MntRNAi. Indeed, the ablation of Mnt protein expression was similar to the effects of Myc in inducing E2f1 expression in MEFs (5) and in inducing Odc in all three fibroblast strains ( Fig. 7A and B) . Previously it has been established that the ability of Myc to provoke accelerated proliferation is E2f1 dependent (5). We therefore transduced E2f1-deficient MEFs with MSCV-MntRNAi-IRES-GFP virus or control GFP-onlyexpressing virus and sorted GFP-expressing cells by FACS.
Strikingly, knockdown of Mnt expression in E2f1
Ϫ/Ϫ MEFs (data not shown) failed to alter their morphology or to provoke accelerated growth (Fig. 3C) . Therefore, the effects of Mnt knockdown on cell proliferation are, as in the scenario of Myc overexpression, E2f1 dependent. Finally, another hallmark of the ability of Myc to provoke accelerated cell cycle traverse is the down-regulation of the universal cyclin-dependent kinase inhibitor p27
KipI (39) , and all three fibroblast strains expressing MntRNAi displayed markedly reduced levels of p27 KipI (Fig.  7A) .
The induction of apoptosis in MntRNAi-expressing fibroblasts when deprived of serum suggested that knockdown of Mnt may provoke apoptosis via typical mediators of Mycinduced cell death, for example by activating the Arf-p53 tumor suppressor pathway (40) and/or by suppressing the expression of the anti-apoptotic Bcl-X L protein (13) . Indeed, in MEFs expressing MntRNAi, Arf and p53 expression were highly elevated, and in all three MntRNAi-expressing fibroblast strains, the expression of Bcl-X L protein was effectively abolished (Fig. 7C) . Myc is also capable of stabilizing and activating p53 in the absence of Arf (23) and in c-myc
Rat1a fibroblasts and immortal BALB/c-3T3 fibroblasts Mnt
RNAi expression was associated with massive increases in p53 protein levels (Fig. 7C) . Thus, knockdown of Mnt also mimics Myc in its ability to regulate apoptotic pathways.
DISCUSSION
Through reinterrogating how Myc actually induces Odc transcription, we uncovered the surprising finding that the gene is Arf -p53 apoptotic pathway and the Bcl-X L apoptotic pathway are triggered by Mnt loss. Knockdown of Mnt was associated with an increase in p53 levels in all fibroblasts and with the induction of Arf in MEFs. The loss of Mnt was also associated with the activation of caspase-9, since larger (inactive) proenzyme form of caspase-9 was lost in MntRNAi-expressing fibroblasts. Again, the absence of caspase-9 protein in the c-myc Ϫ/Ϫ cells may reflect the inability of this antibody to recognize rat caspase-9. Bcl-X L protein levels were dramatically reduced in all MntRNAi-expressing fibroblast strains. (Fig. 8) . However, a totally unexpected finding was that Mnt ablation essentially mimicked many of the transcriptional programs provoked by Myc and that this could occur even in cells lacking all forms of Myc. This would then argue that Mnt-mediated repression is the focal point for transcriptional control (Fig. 8) and that Myc oncoproteins really activate transcription indirectly by effectively blocking Mnt functions.
The parallels between Mnt knockdown and Myc overexpression are striking at many levels. Although interrogating the genomic response is clearly a priority, it is already evident that besides Odc, many other genes that are normally triggered by Myc are also regulated by Mnt loss. The biological responses to Mnt knockdown also recapitulate the effects of Myc overexpression, including accelerated cell proliferation (40), apoptosis following the withdrawal of survival factors (1, 14) , and transformation in conjunction with activated Ha-Ras (22) . Interestingly, the notion that relieving Mnt-mediated transrepression is sufficient to activate genes involved in transformation is supported by experiments demonstrating that a deletion mutant of Mnt lacking the Sin3 interaction domain is capable of transforming primary rat embryo fibroblasts in conjunction with Ha-Ras (20) . This strengthens our view that Myc activates some target genes by merely relieving Mnt-mediated transrepression.
Surprisingly modest phenotypes have been observed in the mouse knockouts of the Mad family members of the Max network. For example, hematopoietic cells from Mad1 knockout mice do exhibit an increased sensitivity to apoptosis following growth factor withdrawal ex vivo, yet Mad1 loss does not alter the hematopoietic compartment in vivo (15) . Further, MEFs from Mxi1-deficient mice are more prone to transformation, yet this is manifest only in the presence of both activated Ras and Myc (36) . Finally, Mad3-deficient thymocytes and neural progenitor cells exhibit increased sensitivity to DNA damage (35) , a phenotype also manifested following Myc overexpression (26) . However, none of these knockouts come close to having the profound effects observed following Mnt knockdown, which in many respects appears to phenocopy the effects of Myc overexpression as seen in cancer. Indeed our studies are largely supported by the very recent and initial characterization of the mouse Mnt knockout, since MEFs from these mice display accelerated growth and apoptosis and since loss of Mnt can lead to breast cancer (21) . However, there are important differences in the cast of "Myc" targets expressed in MEFs from these mice and those expressed in our Mnt knockdown cells, suggesting that some level of compensation for Mnt loss may be operational during development (as would be expected for a proapoptotic signal).
Most importantly, the results presented here challenge many of the conventional notions of how Myc functions to regulate gene transcription, cell proliferation, apoptosis, and transformation. Heretofore, the Mad and Mnt transcriptional repressors have been suggested to antagonize Myc (Fig. 8A) . However, the data herein suggest that it may be Myc that functions as an antagonist, by specifically relieving Mnt-mediated repression (Fig. 8B) . These results specifically support a model whereby the function of Myc as an oncogene relies on its ability to block Mnt activity. At face value, these findings would predict that Mnt is a bona fide tumor suppressor and that it should be inactivated in human cancers. Here we establish that this is probably true for every tumor that overexpresses Myc. Alternatively, the current failure to detect direct inactivation of MNT in human tumors (37, 38) could reflect the profound apoptotic response observed following Mnt loss, since, for example, knockdown of Mnt is more lethal than Myc overexpression in primary hematopoietic progenitors (J. A. Nilsson and J. L. Cleveland, unpublished data). Finally, this model also explains why Myc overexpression is such a pervasive event in cancer-increasing the thresholds of Myc would specifically override the transcriptional repression and tumor suppressor functions of Mnt.
